(Q38025028)

27 August 2017

title

Schizophrenia and substance abuse comorbidity: nicotine addiction and the neonatal quinpirole model (English)

1 reference

27 August 2017

1 reference

1 reference

1 reference

Russell W Brown

1

1 reference

27 August 2017

Amanda M Maple

2

1 reference

27 August 2017

Marla K Perna

3

1 reference

27 August 2017

A Brianna Sheppard

4

1 reference

27 August 2017

Zackary A Cope

5

1 reference

27 August 2017

Richard M Kostrzewa

6

1 reference

27 August 2017

publication date

6 July 2012

1 reference

Developmental Neuroscience

27 August 2017

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

27 August 2017

volume

34

1 reference

27 August 2017

issue

2-3

1 reference

27 August 2017

page(s)

140-151

1 reference

A Nicotine Challenge to the Self-Medication Hypothesis in a Neurodevelopmental Animal Model of Schizophrenia

27 August 2017

cites work

1 reference

Affect recognition deficits in schizophrenia: neural substrates and psychopharmacological implications

21 January 2018

1 reference

Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

21 January 2018

1 reference

Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine induced activity.

21 January 2018

1 reference

Idazoxan blocks the nicotine-induced reversal of the memory impairment caused by the NMDA glutamate receptor antagonist dizocilpine

21 January 2018

1 reference

Influence of social isolation in the rat on serotonergic function and memory--relevance to models of schizophrenia and the role of 5-HT₆ receptors

21 January 2018

1 reference

A neurodevelopmental model of schizophrenia: Neonatal disconnection of the hippocampus

21 January 2018

1 reference

Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood

21 January 2018

1 reference

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia

21 January 2018

1 reference

The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications

21 January 2018

1 reference

A review of the effects of nicotine on schizophrenia and antipsychotic medications

21 January 2018

1 reference

Cigarette smoking among patients with mental retardation and mental illness.

21 January 2018

1 reference

Mortality and causes of death in first admitted schizophrenic patients

21 January 2018

1 reference

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms

21 January 2018

1 reference

The impact of the CYP2D6 polymorphism on haloperidol pharmacokinetics and on the outcome of haloperidol treatment.

21 January 2018

1 reference

Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine

21 January 2018

1 reference

Cigarette smoking: implications for psychiatric illness

21 January 2018

1 reference

The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions

21 January 2018

1 reference

Plasma clozapine concentration coefficients of variation in a long-term study

21 January 2018

1 reference

Why do patients with schizophrenia smoke?

21 January 2018

1 reference

Nicotine exposure and tardive dyskinesia

21 January 2018

1 reference

Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients.

21 January 2018

1 reference

Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues

21 January 2018

1 reference

Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity

21 January 2018

1 reference

Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia.

21 January 2018

1 reference

Accentuated behavioral sensitization to nicotine in the neonatal ventral hippocampal lesion model of schizophrenia

21 January 2018

1 reference

Ketamine induces hyperactivity in rats and hypersensitivity to nicotine in rat striatal slices

21 January 2018

1 reference

Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating

21 January 2018

1 reference

Chronic nicotine and dizocilpine effects on nicotinic and NMDA glutamatergic receptor regulation: interactions with clozapine actions and attentional performance in rats

21 January 2018

1 reference

Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.

21 January 2018

1 reference

Adolescence, schizophrenia and drug abuse: a window of vulnerability

21 January 2018

1 reference

Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study

21 January 2018

1 reference

Characteristics of smokers with a psychotic disorder and implications for smoking interventions

21 January 2018

1 reference

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

21 January 2018

1 reference

Dopamine receptor supersensitivity

21 January 2018

1 reference

All Roads to Schizophrenia Lead to Dopamine Supersensitivity and Elevated Dopamine D2High Receptors

21 January 2018

1 reference

Dopamine in schizophrenia: a review and reconceptualization

21 January 2018

1 reference

Stress and the progression of the developmental hypothesis of schizophrenia.

21 January 2018

1 reference

Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment

21 January 2018

1 reference

Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia

21 January 2018

1 reference

Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats.

21 January 2018

1 reference

The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole

21 January 2018

1 reference

Adulthood olanzapine treatment fails to alleviate decreases of ChAT and BDNF RNA expression in rats quinpirole-primed as neonates

21 January 2018

1 reference

Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression

21 January 2018

1 reference

The effects of eticlopride on Morris water task performance in male and female rats neonatally treated with quinpirole

21 January 2018

1 reference

Amphetamine locomotor sensitization and conditioned place preference in adolescent male and female rats neonatally treated with quinpirole

21 January 2018

1 reference

Cocaine exposure during the brain growth spurt: studies of neonatal survival, somatic growth, and brain development.

21 January 2018

1 reference

Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior

21 January 2018

1 reference

Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232.

21 January 2018

1 reference

Ontogenetic quinpirole treatment produces long-lasting decreases in the expression of Rgs9, but increases Rgs17 in the striatum, nucleus accumbens and frontal cortex

21 January 2018

1 reference

Regulators of G protein signaling (RGS proteins): novel central nervous system drug targets

21 January 2018

1 reference

Regulators of G-protein signalling as new central nervous system drug targets.

21 January 2018

1 reference

Cellular regulation of RGS proteins: modulators and integrators of G protein signaling

21 January 2018

1 reference

Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain

21 January 2018

1 reference

Psychosis pathways converge via D2high dopamine receptors

21 January 2018

1 reference

The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole

21 January 2018

1 reference

Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis

21 January 2018

1 reference

Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics

21 January 2018

1 reference

Nicotine sensitization in adult male and female rats quinpirole-primed as neonates

21 January 2018

1 reference

Sex differences in nicotine sensitization and conditioned hyperactivity in adolescent rats neonatally treated with quinpirole: role of D2 and D3 receptor subtypes

21 January 2018

1 reference

Nicotine-conditioned locomotor sensitization in rats: assessment of the US-preexposure effect

21 January 2018

1 reference

Effects of mecamylamine on nicotine-induced conditioned hyperactivity and sensitization in differentially reared rats

21 January 2018

1 reference

Examination of GABAergic and dopaminergic compounds in the acquisition of nicotine-conditioned hyperactivity in rats

21 January 2018

1 reference

An analysis of nicotine conditioned place conditioning in early postweanling and adolescent rats neonatally treated with quinpirole.

21 January 2018

1 reference

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

21 January 2018

1 reference

Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model.

21 January 2018

1 reference

Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.

21 January 2018

1 reference

Animal models of periadolescent substance abuse

21 January 2018

1 reference

The adolescent brain and age-related behavioral manifestations

21 January 2018

1 reference

Sex differences in dopamine receptors and their relevance to ADHD.

21 January 2018

1 reference

Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood

21 January 2018

1 reference

Regulation of glutamate release by α7 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals

21 January 2018

1 reference

Neuroimaging of Nicotine Dependence: Key Findings and Application to the Study of Smoking-Mental Illness Comorbidity

21 January 2018

1 reference

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

21 January 2018

1 reference

Personality, psychopathology, and nicotine response as mediators of the genetics of smoking

21 January 2018

1 reference

Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

21 January 2018

1 reference

Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia

21 January 2018

1 reference

Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses

21 January 2018

1 reference

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000338830

1 reference

27 August 2017

1 reference